We recently published 10 Trending Stocks Moving These Days. Novo Nordisk A/S (NYSE:NVO) is one of the trending stocks moving ...

Novo Nordisk, which lobbied to win Medicaid reimbursement for its obesity drug Wegovy, is fighting to keep that coverage as ...

Novo Nordisk faces a challenge in tapping into the U.S. mass market for weight-loss drugs. With new board leadership, the ...

A boardroom shake-up at Novo Nordisk has handed unprecedented power to its top shareholder, the Novo Nordisk Foundation, ...

COPENHAGEN (Reuters) -Novo Nordisk shares fell as much as 6.4% in early Friday trade after U.S. President Donald Trump ...

The president said the cost of the drug should be much lower for Americans once negotiations with Novo Nordisk had concluded.

Barron’s spoke with Dave Moore, executive vice president of U.S. operations, about Wegovy as a pill, rather than an injection.

Novo Nordisk, the Danish pharmaceutical giant, is undergoing significant restructuring, resulting in layoffs at its largest U.S. manufacturing plant in North Carolina. The company is focusing on cost ...

Novo Nordisk and Eli Lilly stocks fell after Trump announced Ozempic prices could drop to $150 monthly from $1,000.

Shares of Eli Lilly and Novo Nordisk move lower in Thursday's after-hours session after President Trump indicated weight-loss ...

Another week, another twist in the turnaround efforts at Novo Nordisk, the maker of the blockbuster Ozempic and Wegovy weight ...

() -London-based startup SheMed, which offers personalized weight-loss plans using popular medicines Wegovy and Mounjaro, said on Thursday it has raised $50 million in its Series A funding round to ...